Karla Ballman, Ph.D., specializes in designing clinical trials, analyzing complex data, and developing molecular signatures that can help predict whether or not a cancer patient will respond to targeted therapies. She most recently was a professor of biostatistics at the Mayo Clinic College of Medicine and a consultant in the Division of Biomedical Statistics and Informatics at the Mayo Clinic in Rochester, Minn. She is also a former chair of the Division of Biostatistics at Mayo.

Dr. Ballman, who is also an associate editor for the high-impact Journal of Clinical Oncology, has spent the last 16 years working in medical statistics, 13 of them in cancer biostatistics. She’s received research grants from the National Cancer Institute and National Institutes of Health and served as biostatistics core director for a prostate Specialized Programs of Research Excellence (SPORE) grant and for a brain cancer SPORE.